Pancreatic Cancer Research

ResearcherUppsala UniversityNo recent work listed

Anders Nilsson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-8430-4166; OpenAlex author ID A5111033387. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper

Papers 5

  1. Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection. First author DOI 10.21873/anticanres.14249↗
  2. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13371↗
  3. The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer. First author DOI 10.21873/anticanres.13827↗
  4. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Co-author DOI 10.1016/j.ejso.2016.01.024↗
  5. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer. Last author PMID 24403476↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher Månsson · 5 shared papers, 2014–2020 · strength 0.54
  2. Britt‐Marie Karlson · 5 shared papers, 2014–2020 · strength 0.54
  3. Magnus Bergenfeldt · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.